Hikma Pharmaceuticals

Hikma Pharmaceuticals Plc has a rich story of 41 years of business. It was founded in Amman, Jordan in 1978 by Samih Darwazah. The purpose of its founding was to offer affordable and high-quality medicines.

The company has set the pace of being a prominent supplier of in-licensed products as well as branded generics. From humble beginnings, it is now a global pharmaceutical business with its headquarters in London, UK. It has had several acquisitions, which have scaled up its current growth.

Hikma is in the business of shaping a healthier world. Through practical solutions, it has been transforming people’s lives, thanks to its broad range of products.

The company has taken up an added obligation of helping its communities. This is the reason why it carries out charity work through donations to institutions helping people suffering from natural disasters. The multinational pharmaceutical company is listed on the LSE market, but every day, it is striving to enrich lives.

Latest Hikma Pharmaceuticals News

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.